The Malay Dilemma Revisited is a critical and balanced analysis of Malaysia's preferential race policy and its impact on the nation's delicate race dynamics and economy. Unlike America's affirmative action, Malaysia's version is far more aggressive and pervasive and has been remarkably successful in creating a sizable and stable Bumiputra (indigenous group) middle class. The price tag is significant: distortion of freemarket dynamics and consequent inefficiency. Perversely, the policy impairs rather than strengthens Bumiputras' ability to compete. In contrast to quotas and other set-aside programs that are the hallmark of the current policy, the writer presents an alternative strategy aimed primarily at enhancing Bumiputra competitiveness. The proposed approach would not negatively impact the economy nor interfere with the freemarket. Equally important, it would not arouse resentment from other Malaysians. The first objective would be to modernize the nation's archaic educational system to emphasize English, mathematics, the sciences, and technical training. Secondly, the influences of religious and royal institutions must be curtailed, and the rates of urbanization and population growth reduced. The primary objective is in enhancing competitiveness, not on meeting arbitrarily picked numerical goals and targets.

A study examining research and development projects and capital improvements, and changes in productivity and profitability in selected American manufacturing industries and companies from 1980 to 1989. Special attention is given to the effects of substantial investment increases on productivity and profitability changes. Annotation copyright by Book News, Inc., Portland, OR

This booklet is based on the Estimates and Projections of Family Planning Indicators 2019, which includes estimates at the global, regional and country level of contraceptive prevalence, unmet need for family planning and SDG indicator 3.7.1 "Proportion of women who have their need for family planning satisfied by modern methods".

The "contraceptive revolution" of the 1960s and 1970s introduced totally new contraceptive options and launched an era of research and product development. Yet by the late 1980s, conditions had changed and improvements in contraceptive products, while very important in relation to improved oral contraceptives, IUDs, implants, and injectables, had become primarily incremental. Is it time for a second contraceptive revolution and how might it happen? Contraceptive Research and Development explores the frontiers of science where the contraceptives of the future are likely to be found and lays out criteria for deciding where to make the next R&D investments. The book comprehensively examines today's contraceptive needs, identifies "niches" in those needs that seem most readily translatable into market terms, and scrutinizes issues that shape the market: method side effects and contraceptive failure, the challenge of HIV/AIDS and other sexually transmitted diseases, and the implications of the "women's agenda." Contraceptive Research and Development analyzes the response of the pharmaceutical industry to current dynamics in regulation, liability, public opinion, and the economics of the health sector and offers an integrated set of recommendations for public- and private-sector action to meet a whole new generation of demand.

For patients and their loved ones, no care decisions are more profound than those made near the end of life. Unfortunately, the experience of dying in the United States is often characterized by fragmented care, inadequate treatment of distressing symptoms, frequent transitions among care settings, and enormous care responsibilities for families. According to this report, the current health care system of rendering more intensive services than are necessary and desired by patients, and the lack of coordination among programs increases risks to patients and creates avoidable burdens on them and their families. Dying in America is a study of the current state of health care for persons of all ages who are nearing the end of life. Death is not a strictly medical event. Ideally, health care for those nearing the end of life harmonizes with social, psychological, and spiritual support. All people with advanced illnesses who may be approaching the end of life are entitled to access to high-quality, compassionate, evidence-based care, consistent with their wishes. Dying in America evaluates strategies to integrate care into a person- and family-centered, team-based framework, and makes recommendations to create a system that coordinates care and supports and respects the choices of patients and their families. The findings and recommendations of this report will address the needs of patients and their families and assist policy makers, clinicians and their educational and credentialing bodies, leaders of health care delivery and financing organizations, researchers, public and private funders, religious and community leaders, advocates of better care, journalists, and the public to provide the best care possible for people nearing the end of life.